Understand the evolving child-resistant packaging market and current regulations
Despite a reduction in cases in recent years, unintentional child poisoning remains a considerable risk in the home, with over-the-counter and prescription medicines presenting the greatest risk. Patients and stakeholders are calling upon the pharmaceutical industry to recognize the importance of child-resistant closures (CRCs) in medical packaging that is effective at preventing young children opening medication, while remaining accessible to senior patients. By partnering with packaging manufacturers that can offer certified child-resistant packaging solutions, pharmaceutical companies can guarantee their products meet relevant regulatory requirements, avoid brand damage and fines through non-compliance, and keep children safe from poisoning.
Download the white paper to learn:
- How current trends are driving developments in child-resistant packaging
- The role of pharmaceutical companies in driving CRC awareness and innovation in the industry
- The results of recent research into both novel approaches to packaging design, and proposed changes to current child-resistant packaging test criteria
- The opinions of industry experts on the future of the child-resistant packaging landscape
- How strong collaborations between drug manufacturers and packaging suppliers accelerate advances in child-resistant packaging.
Free webinar: Why pharma packaging choice matters in protecting children’s lives?
20 May 2021 - 4PM Paris/3PM London /10AM New York
An evaluation of current and future trends in the pharmaceutical industry
Unintentional child poisoning remains a global societal issue and a considerable risk in the home. In the United States (U.S.), every day, two children die because of poisoning. In the European Union (EU), poisoning is the fifth leading cause of unintentional death for children. One of the most commonly cited causes of poisoning is accidental ingestion of medicinal drugs. Despite a downward trend in poisoning cases thanks to better regulations and awareness, the risk of poisoning still exists, and patients and stakeholders are calling on pharmaceutical companies to recognize the importance of child- resistant closures (CRCs) in medical packaging. Since its introduction, child-resistant packaging has developed to become a must-have in some regions and is rapidly gaining acceptance in others. However, discrepancies between regions still exists and some reluctancy persists. An important feature of child-resistant packaging is the ability of older patients to access medication, while simultaneously ensuring children cannot open it. While most packaging solutions must meet child-resistant senior friendly (CRSF) certification protocols, concern remains around the impact of CRCs on elderly patient compliance. This webinar will cover these trends, and reviews current research and viewpoints of the industry in child-resistant packaging innovation.
Watch out for free here